Mylan on defensive again after complaints of reported EpiPen failures

Mylan on defensive again after complaints of reported EpiPen failures

November three, 2017, 7:32 AM|
Mylan, the drug firm that created outrage with the dramatic value hike of the EpiPen, is on the defensive once more. A brand new report exhibits an enormous rise in complaints in regards to the gadget not working in life-threatening emergencies. Tony Dokoupil reviews.